Federal Register Notices - 2022

Below are Federal Register Notices published in 2022 by the United States Patent and Trademark Office. Selected Federal Register Notices may also appear under various topical areas on this USPTO website.

For a complete, searchable database of Federal Register Notices from the USPTO in PDF, XML, and accessible HTML formats, please visit http://www.regulations.gov.

Final Rules

  • None at this time

Interim Rules

  • None at this time

Proposed Rules

  • Changes to the Representation of Others Before the United States Patent and Trademark Office, 54930–54937 [2022–18215] [TEXT] [PDF] (08Sep2022)
  • Standardization of the Patent Term Adjustment Statement Regarding Information Disclosure Statements, 41267–41271 [2022–14668] [TEXT] [PDF] (12Jul2022)
  • Establishing Permanent Electronic Filing for Patent Term Extension Applications, 27043–27048 [2022–09535] [TEXT] [PDF] (06May2022)

General Notices

  • Grant of Interim Extension of the Term of U.S. Patent: No. 6,406,699; ECI (ELIAS Cancer Immunotherapy), 59063 [2022–21118] [TEXT] [PDF] (29Sep2022)
  • Grant of Interim Extension of the Term of U.S. Patent: No. 7,199,162; Grafapex (Treosulfan), 59064 [2022–21117] [TEXT] [PDF] (29Sep2022)
  • Extension of the Cancer Immunotherapy Pilot Program, 58772–58773 [2022–20988] [TEXT] [PDF] (28Sep2022)
  • Director Review, Precedential Opinion Panel Review, and Internal Circulation and Review of Patent Trial and Appeal Board Decisions, 58330–58331 [2022–20697] [TEXT] [PDF] (26Sep2022)
  • Patent Subject Matter Eligibility Guidance, 53736–53737 [2022–18895] [TEXT] [PDF] (01Sep2022)
  • Performance Review Board Membership, 52753 [2022–18543] [TEXT] [PDF] (29Aug2022)
  • Duties of Disclosure and Reasonable Inquiry During Examination, Reexamination, and Reissue, and for Proceedings Before the Patent Trial and Appeal Board [2022-15475] [TEXT] [PDF] (29Jul2022)
  • Request for Comments on Director Review, Precedential Opinion Panel Review, and Internal Circulation and Review of Patent Trial and Appeal Board Decisions, 43249-43252 [2022–15475] [TEXT] [PDF] (20Jul2022)
  • Trademarks USPTO.gov Account ID Verification Program, 41114–41116 [2022–14435] [TEXT] [PDF] (11Jul2022)
  • Prioritized Examination Pilot Program for Patent Applications: Modified COVID–19 Program; Fourth Extension, 38714 [2022–13892] [TEXT] [PDF] (29Jun2022)
  • Request for Comments: Extension of the Cancer Immunotherapy Pilot Program, 38714–38715 [2022–13908] [TEXT] [PDF] (29Jun2022)
  • Artificial Intelligence and Emerging Technologies Partnership, 34669–34671 [2022–12139] [TEXT] [PDF] (07Jun2022)
  • Climate Change Mitigation Pilot Program, 33750–33753 [2022–11930] [TEXT] [PDF] (03Jun2022)
  • Requests for Nominations: Patent and Trademark Public Advisory Committees, 31861–31862 [2022–11200] [TEXT] [PDF] (25May2022)
  • Acceleration of Transition to Issuance of Certificates, 31533 [2022–11196] [TEXT] [PDF] (24May2022)
  • Electronic Trademark Registration Certificates, 25623–25624 [2022–09335] [TEXT] [PDF] (02May2022)
  • Grant of Interim Patent Term Extension: U.S. Patent No. 9,364,354; Reducer, 23858 [2022–08492] [TEXT] [PDF] (21Apr2022)
  • Expanded Collaborative Search Pilot Program: New Combined Petition Option For Participation; Withdrawal, 21642 [2022–07909] [TEXT] [PDF] (12Apr2022)
  • Termination of Global Patent Prosecution Highway with Rospatent, 19486 [2022–06885] [TEXT] [PDF] (04Apr2022)
  • Expanded Collaborative Search Pilot Program: New Combined Petition Option for Participation, 17995–17996 [2022–06602][TEXT] [PDF] (29Mar2022)
  • Prioritized Examination Pilot Program for Patent Applications: Modified COVID–19 Program; Third Extension, 17073–17074 [2022–06294] [TEXT] [PDF] (25Mar2022)
  • Grant of Interim Extension of the Term of U.S. Patent: No. 6,953,476; Reducer, 13278 [2022–04970] [TEXT] [PDF] (09Mar2022)
  • Grant of Interim Extension of the Term of U.S. Patent: No. 8,858,612; Reducer, 13278 [2022–04969] [TEXT] [PDF] (09Mar2022)
  • Charter Renewal: National Medal of Technology and Innovation Nomination Evaluation Committee, 9042 [2022–03443] [TEXT] [PDF] (17Feb2022)
  • Deferred Subject Matter Eligibility Response Pilot Program, 776–780 [2021–28473] [TEXT] [PDF] (06Jan2022)
  • Trademarks Administrative Sanctions Process, 431–432 [2021–28536] [TEXT] [PDF] (05Jan2022)

Paperwork Reduction Act

30-Day Notices (Notice of Submission to OMB)

  • [0651-0071] - Matters Related to First Inventor to File [TEXT] [PDF] (20 January 2022)
  • [0651-0066] - Patents for Humanity Program [TEXT] [PDF] (18 February 2022)
  • [0651-0069] - Patent Review and Derivation Proceedings [TEXT] [PDF] (24 February 2022)
  • [0651-0079] - International Work Sharing Program [TEXT] [PDF] (25 March 2022)
  • [0651-0017] - Practitioner Conduct and Discipline [TEXT] [PDF] (25 April 2022)
  • [0651-0051] - Madrid Protocol [TEXT] [PDF] (25 April 2022)
  • [0651-0057] - Patents External Quality Survey [TEXT] [PDF] (24 May 2022)
  • [0651-0087] - COVID-19 Vaccine Supplemental Medicine Provider Statement [TEXT] [PDF] (31 May 2022)
  • [0651-0044] - Invention Promoters/Promotion Firms Complaints [TEXT] [PDF] (23 June 2022)
  • [0651-NEW] - Improving Customer Experience (OMB Circular A-11, Section 280 Implementation) [TEXT] [PDF] (16 August 2022)
  • [0651-0024] - Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures [TEXT] [PDF] (16 September 2022)

60-Day Notices (Notice of Proposed Collection)

  • [0651-0017] - Practitioner Conduct and Discipline [TEXT] [PDF] (8 February 2022)
  • [0651-0051] - Madrid Protocol [TEXT] [PDF] (9 February 2022)
  • [0651-0057] - Patents External Quality Survey [TEXT] [PDF] (15 March 2022)
  • [0651-0087] - COVID-19 Vaccine Supplemental Medicine Provider Statement [TEXT] [PDF] (24 March 2022)
  • [0651-0044] - Invention Promoters/Promotion Firms Complaints [TEXT] [PDF] (31 March 2022)
  • [0651-NEW] - Improving Customer Experience (OMB Circular A-11, Section 280 Implementation) [TEXT] [PDF] (24 May 2022)
  • [0651-0024] - Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures [TEXT] [PDF] (7 June 2022)
  • [0651-0021] - Patent Cooperation Treaty [TEXT] [PDF] (2 August 2022)
  • [0651-0082] - Patent and PTAB Pro Bono Programs [TEXT] [PDF] (30 August 2022)
  • [0651-0046] - Legal Processes [TEXT] [PDF] (16 September 2022)

Privacy Act

System of Records Notices

  • None at this time